BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18268526)

  • 1. Do we need new indicators of dialysis adequacy based on middle-molecule removal?
    Vanholder R; Eloot S; Van Biesen W
    Nat Clin Pract Nephrol; 2008 Apr; 4(4):174-5. PubMed ID: 18268526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 3. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of dialysis membranes in elimination of uremic toxins].
    Grzeszczak W; Zukowska-Szczechowska E; Rutkowski B
    Przegl Lek; 1996; 53(5):439-42. PubMed ID: 8754410
    [No Abstract]   [Full Text] [Related]  

  • 6. Uraemic toxins.
    Dawborn JK
    Aust N Z J Med; 1981; 11(Suppl 1):40-5. PubMed ID: 6942801
    [No Abstract]   [Full Text] [Related]  

  • 7. Dialysis therapy: 'think differently'.
    Perrone B
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v1-2. PubMed ID: 17586840
    [No Abstract]   [Full Text] [Related]  

  • 8. [Removal of middle molecule peptides from the blood during hemodialysis].
    Bakaev VV; Khomenko VF
    Lab Delo; 1989; (1):64. PubMed ID: 2468036
    [No Abstract]   [Full Text] [Related]  

  • 9. Membranes and their removal of uremic toxins.
    Hoenich NA
    Adv Exp Med Biol; 1987; 223():253-62. PubMed ID: 3447443
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of middle molecules: clinical evaluation using a selective filtration artificial kidney.
    Jörstad S; Smeby LC; Wideröe TE
    Artif Organs; 1981; 4 Suppl():98-103. PubMed ID: 7295103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medium-sized molecules and the process of uremic intoxication].
    Lutz W
    Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302
    [No Abstract]   [Full Text] [Related]  

  • 13. Removal of waste metabolites in uremia by microencapsulated reactants.
    Sparks RE; Salemme RM; Meier PM; Litt MH; Lindan O
    Trans Am Soc Artif Intern Organs; 1969; 15():353-9. PubMed ID: 5791409
    [No Abstract]   [Full Text] [Related]  

  • 14. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of uraemic toxins by haemofiltration with different membranes. The benefit of regenerating haemofiltrate using a newly developed system.
    Jörstad S; Smeby LC; Wideröe TE; Berg KJ
    Proc Eur Dial Transplant Assoc; 1979; 16():212-7. PubMed ID: 548983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of high-molecular-weight toxins.
    Hörl WH
    Contrib Nephrol; 1992; 96():138-44. PubMed ID: 1740048
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intestinal elimination of uremic metabolites by the adsorbents].
    Drüeke T
    Med Klin; 1976 Jan; 71(3):87-93. PubMed ID: 233947
    [No Abstract]   [Full Text] [Related]  

  • 18. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?
    Vanholder R; Van Laecke S; Glorieux G
    J Nephrol; 2008; 21(2):146-60. PubMed ID: 18446708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal strategies for the removal of middle molecules.
    Winchester JF; Audia PF
    Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dialysis adequacy.
    Gotch FA
    Contrib Nephrol; 1989; 69():101-8; discussion 162-7. PubMed ID: 2661134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.